Liver transplantation in man--3, Studies of liver function, histology, and immunosuppressive therapy

• Published in: British medical journal 1969-07, Vol.3 (5661), p.12-19
• Main Authors: Williams, R, Calne, R Y, Ansell, I D, Ashby, B S, Cullum, P A, Dawson, J L, Eddleston, A L, Evans, D B, Flute, P T, Herbertson, P M, Joysey, V, McGregor, A M, Millard, P R, Murray-Lyon, I M, Pena, J R, Rake, M O, Sells, R A
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Antilymphocyte Serum - therapeutic use; Biliary Fistula - surgery; Biliary Tract - abnormalities; Carcinoma, Hepatocellular - surgery; Child, Preschool; Cholestasis - drug therapy; Cholestasis - etiology; Cholestasis - pathology; Drainage; Female; Histocompatibility; Humans; Infant; Liver - pathology; Liver - physiology; Liver Cirrhosis - surgery; Liver Function Tests; Liver Neoplasms - surgery; Liver Transplantation; Male; Middle Aged; Pneumonia - etiology; Postoperative Complications; Prednisone - therapeutic use; Transplantation Immunology; Transplantation, Homologous
• ISSN: 0007-1447
• DOI: 10.1136/bmj.3.5661.12

The experience gained from 13 hepatic transplant operations is described, with particular reference to the findings in nine patients who survived the immediate operative period. A major problem was found to be infection. Fulminant pneumonia caused death in two adults, at a time when liver function was virtually normal. Infection related to bile fistula and sepsis may be overcome by an improved method of biliary drainage by cholecyst-dochostomy, which was carried out in the last two patients. Jaundice in the second week due to rejection was observed in several patients. The striking histological change was centrilobular cholestasis. The jaundice, which was not prevented by administration of antilymphocyte globulin, was rapidly controlled by temporarily increasing die dose of prednisone. One patient who survived for four and a half months and who had a poor tissue match subsequently developed chronic rejection with progressive cholestatic jaundice. Five of the patients were able to go home and at time of publication two are alive and well 14 and 20 weeks after treatment.